Advanced glycation end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process Cross-link breakers as a […]

 Slimming food supplements adulterated with sibutramine and phenolphthalein  Too Fat Part Two!… … , double-blind, placebo-controlled, linear dose, crossover study to

STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells Sugar absorption in the intestine: the role of GLUT2 Glucose sensing

The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase A new pancreatic lipase inhibitor

AMPK activation: a therapeutic target for type 2 diabetes? AMPK activators–potential therapeutics for metabolic and other diseases AMPK activation, a

Of mice and men: The physiological role of adipose triglyceride lipase (ATGL) Hints on ATGL implications in cancer: beyond bioenergetic

Possible anti-obesity therapeutics from nature–A review Anti-obesity drugs: past, present and future Anti-obesity drugs: a review about their effects and

GSK3 inhibitors: development and therapeutic potential The conundrum of GSK3 inhibitors: is it the dawn of a new beginning? Discovery

SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages Sirt 1 activator inhibits the AGE-induced apoptosis and p53